FFNIX | HBLVX | FFNIX / HBLVX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 17 years | 10 years | - |
Gain YTD | 8.024 | 8.757 | 92% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | 500 | N/A | - |
Net Assets | 2.29B | 12.7B | 18% |
Annual Yield % from dividends | 2.38 | 3.62 | 66% |
Returns for 1 year | 14.54 | 15.10 | 96% |
Returns for 3 years | 1.00 | 1.55 | 65% |
Returns for 5 years | 23.22 | 19.10 | 122% |
Returns for 10 years | 39.36 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GMVCX | 15.85 | 0.02 | +0.13% |
Goldman Sachs Small/Mid Cap Value C | |||
ASIMX | 13.80 | -0.02 | -0.14% |
Alger Weatherbie Specialized Growth I | |||
HUMDX | 15.83 | -0.03 | -0.19% |
Huber Mid Cap Value Inv | |||
JNGLX | 81.18 | -0.16 | -0.20% |
Janus Henderson Global Life Sciences D | |||
PGRRX | 44.32 | -0.10 | -0.23% |
Pioneer Select Mid Cap Growth R |